Influence of Expectations on Rumination
NCT03869424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2019-08-16
Summary
The study tries to identify whether positive expectations, induced with an active placebo nasal-spray, have effects on rumination.
Conditions
Interventions
- OTHER
-
Active Placebo labelled as antidepessant
Participants receive an active nasal spray that is in fact a placebo.
Sponsors & Collaborators
-
Philipps University Marburg
lead OTHER
Principal Investigators
-
Winfried Rief, Professor · Philipps-Univeristy of Marburg
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-27
- Primary Completion
- 2019-07-31
- Completion
- 2019-08-14
Countries
- Germany
Study Locations
More Related Trials
-
Prevention of Seasonal Affective Disorder
NCT00046241 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects
NCT00634283 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
NCT06029426 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacology Study of BMS-866949
NCT01124344 ·Status: TERMINATED ·Phase: PHASE1
-
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
NCT00105989 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
NCT00073411 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Desvenlafaxine in Treating Major Depressive Disorder.
NCT04364997 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
NCT00036309 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
NCT02498392 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder
NCT01650740 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of Depression
NCT05849272 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Neurobiology of Depression
NCT01051466 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression
NCT03559192 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
NCT00849693 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Duloxetine in Elderly Patients With Major Depressive Disorder
NCT00062673 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
NCT02476058 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo
NCT04221230 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Antidepressants on White Matter Structure
NCT01492621 ·Status: UNKNOWN ·Phase: PHASE4
-
Seasonal Affective Depression (SAD) Study
NCT00069459 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder
NCT06958692 ·Status: RECRUITING ·Phase: PHASE3
-
A Safety, Efficacy and Tolerability Study of SEP-225289
NCT00584974 ·Status: COMPLETED ·Phase: PHASE2
-
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
NCT00057213 ·Status: COMPLETED ·Phase: PHASE2
-
Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
NCT02934035 ·Status: UNKNOWN
-
Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
NCT00494377 ·Status: COMPLETED ·Phase: PHASE4
-
Study for Evaluating Different Methods of Measuring Depression Treatment Response
NCT00406952 ·Status: COMPLETED ·Phase: NA